03 Jan Komen’s Advocacy Priorities in 2019
Komen San Diego’s robust public policy and advocacy arm ensures the voice and needs of breast cancer patients are heard by policymakers and government regulators across the United States.
As a patient advocacy organization, we know firsthand how breast cancer touches our communities. Every two years, we identify the advocacy issues where Komen’s voice could provide the greatest potential impact on achieving our Bold Goal of reducing the number of breast cancer deaths by 50% in the U.S. by 2026.
Komen is excited to announce its 2019-2020 National Public Policy & Advocacy Priorities that will form the basis for our state and federal advocacy work this year:
Ensure Access to Affordable, High – Quality Health Care
- Protect access to affordable, high-quality health care for all patients.
- Support Medicaid expansion and expanded eligibility for Medicaid’s Breast and Cervical Cancer Treatment Program (BCCTP).
- Ensure continued access to Medicaid coverage without burdensome restrictions.
Advance Breast Cancer Research
- Expand federal funding for all biomedical research, especially breast cancer research conducted at the National Institutes of Health (NIH) and at the Department of Defense (DOD).
- Support state funding for breast cancer research programs conducted through state institutions.
- Support increased education, utilization and access to clinical trials for all patient populations.
Increase Coverage and Access to Breast Cancer Screening and Diagnostic Services
- Support federal and state funding for the Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
- Support policies to modernize NBCCEDP state programs to expand eligibility and provide breast cancer screening and diagnostic services for additional populations.
- Reduce or eliminate out-of-pocket costs for diagnostic imaging.
Reduce Insurance Barriers to Treatment
- Protect patient preference, enhance coverage, reduce cost and address barriers to breast cancer treatments, including those that would require oral parity, preclude specialty tiers, prevent step therapy protocols, prevent non-medical switching and limit patient’s out-of-pocket costs.
Every year, Komen San Diego teams up with affiliates across the state of California to collectively work on public policy as the Komen California Collaborative Public Policy Committee (KCCPPC). Learn more about our legislative accomplishments here.
Susan G. Komen is the non-partisan voice for more than 3.5 million breast cancer survivors and the people who love them.